Covid 19: US company Pfizer claims 90 percent effective vaccine in the third phase
Phase III trial started on July 27
Company in preparation for an application for permission to use emergency
New York: Taking a major step towards an effective vaccine to fight the corona epidemic, US-based pharmaceutical major Pfizer and German biotech firm BioNotech said on Monday that their vaccine was found to be 90 percent effective in fresh clinical trials. Pfizer and BioNotech, engaged in making the coronavirus vaccine, said that the corona vaccine is 90% effective in Phase-3 trials. This is great relief news for the world affected by the Corona epidemic.
The vaccine has been successful in preventing disease by 90 percent
Pfizer President and CEO Albert Bourla called it a great day for science and humanity. The phase-3 clinical study on Sunday was conducted by an external independent data monitoring committee (DMC). The statement released by the company According to the findings, the findings showed that 28 days after the first dose was given and seven days after the second dose was given to the patients, the company said that the analysis revealed that the volunteers tested In them, this vaccine has been more than 90 percent successful in preventing the disease. Studies are currently underway, so the percentage of final vaccine efficacy may vary.
Regulatory authorities around the world will be discussed
The DMC has not reported any serious security concerns and recommends that additional safety and efficacy data should continue to be collected as planned by the study. Both companies have also stated that the data will be used with regulatory authorities around the world will be discussed.
Today is a good day for science and humanity
Pfizer's president and CEO said in a statement, "Today is a great day for science and humanity. Our first set of Phase III Kovid-19 vaccine trials provide preliminary evidence of our vaccine's ability to inhibit the corona. "
'Close to success in ending the global health crisis'
He said that we are reaching this important milestone in our vaccine program at a time when infection rates are setting new records, hospitals are under pressure from overcapacity and the economy is struggling to get back on track. He said that this is happening at a time when the world is in dire need of it. The chairman of Pfizer said that we are close to providing a much-needed success to help people around the world end this global health crisis. Huh.
0 Comments